CDC data show rising GLP-1 use as part of diabetes therapy, reflecting guideline adoption
In a statement, Novo Nordisk, developer of semaglutide, said we recognize that eating disorders are serious conditions and deserve specialized clinical attention from healthcare who treat them
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes
Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD
Kong Q, Pei C, Rahimi G, Mallmann P, Isachenko V
Patients should be advised on the need to maintain their muscle mass through resistance-based exercises and to prioritise adequate protein intake